Müller-Ruchholtz W - Search Results

1

Recognition of HLA-derived peptides in transplant patients.

Zavazava N, Stegmann S, Freese A, Müller-Ruchholtz W. Zavazava N, et al. Transplant Proc. 1995 Feb;27(1):489-90. Transplant Proc. 1995. PMID: 7879072 No abstract available.

2

Interaction of purified HLA class I molecules with alloreactive CTL.

Hausmann R, Zavazava N, Müller-Ruchholtz W. Hausmann R, et al. Transplant Proc. 1991 Aug;23(4):2255-7. Transplant Proc. 1991. PMID: 1871864 No abstract available.

3

Plasma MHC class I expression in cardiac graft patients: donor-specific soluble antigen in a presensitised graft patient.

Zavazava N, Kraatz E, Gassel AM, Müller-Ruchholtz W. Zavazava N, et al. Transplant Proc. 1991 Aug;23(4):2258-60. Transplant Proc. 1991. PMID: 1871865 No abstract available.

4

Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA.

Zavazava N, Hausmann R, Müller-Ruchholtz W. Zavazava N, et al. Transplantation. 1991 Apr;51(4):838-42. doi: 10.1097/00007890-199104000-00019. Transplantation. 1991. PMID: 2014539

5

Affinity-purified HLA class I molecules specifically inhibit a human CTL line in vitro.

Hausmann R, Zavazava N, Müller-Ruchholtz W. Hausmann R, et al. Transplant Proc. 1990 Aug;22(4):1874-5. Transplant Proc. 1990. PMID: 2389467 No abstract available.

6

Expression of soluble class I molecules in healthy persons and renal graft patients.

Zavazava N, Westphal E, Olofsson L, Treumer J, Eckstein V, Müller-Ruchholtz W. Zavazava N, et al. Transplant Proc. 1990 Aug;22(4):1876-7. Transplant Proc. 1990. PMID: 2389468 No abstract available.

7

Evidence that the degeneration of heart valve grafts is immunologic.

Zavazava N, Simon A, Müller-Ruchholtz W. Zavazava N, et al. Transplant Proc. 1995 Jun;27(3):2107-8. Transplant Proc. 1995. PMID: 7792900 No abstract available.

8

Anti-donor antibodies in allogeneic cornea transplantation.

Zavazava N, Duncker G, Jenisch S, Nölle B, Westphal E, Müller-Ruchholtz W. Zavazava N, et al. Transplant Proc. 1995 Feb;27(1):1410-1. Transplant Proc. 1995. PMID: 7878928 Clinical Trial. No abstract available.

9

Clinical relevance of soluble HLA and interaction of papain derived class I molecules with alloreactive CTL.

Zavazava N, Hausmann R, Kraatz E, Müller-Ruchholtz W. Zavazava N, et al. Transpl Int. 1992;5 Suppl 1:S606-8. doi: 10.1007/978-3-642-77423-2_178. Transpl Int. 1992. PMID: 14621888

10

Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals.

Zavazava N, Westphal E, Müller-Ruchholtz W. Zavazava N, et al. J Immunogenet. 1990 Dec;17(6):387-94. doi: 10.1111/j.1744-313x.1990.tb00890.x. J Immunogenet. 1990. PMID: 2096183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters